NCT00003465 Temozolomide in Treating Patients With Anaplastic Oligodendroglioma Status COMPLETED Phase PHASE2
NCT00003464 Temozolomide in Treating Adults With Newly Diagnosed Primary Malignant Glioblastoma Multiforme Status COMPLETED Phase PHASE2
NCT00003463 Carmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade Gliomas Status COMPLETED Phase PHASE1
NCT00003462 Intrathecal Busulfan in Treating Patients With Recurrent, Refractory, or Metastatic Leptomeningeal Tumors Status COMPLETED Phase PHASE1
NCT00003461 Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT00003417 Computer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma Multiforme Status COMPLETED Phase PHASE1/PHASE2
NCT00003410 Motexafin Gadolinium With MRI-Guided Surgery in Treating Patients With High-Grade Gliomas Status COMPLETED Phase PHASE1
NCT00003409 Motexafin Gadolinium Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Status COMPLETED Phase PHASE1
NCT00003375 Observation or Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Low-Grade Glioma Status COMPLETED Phase PHASE2/PHASE3
NCT00003348 Carmustine Plus O(6)-Benzylguanine in Treating Patients With Recurrent or Progressive Gliomas of the Brain Status COMPLETED Phase PHASE1
NCT00003309 Combination Chemotherapy Plus Radiation Therapy in Treating Adult Patients With Brain Cancer Status COMPLETED Phase PHASE2
NCT00003304 Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors Status COMPLETED Phase PHASE2
NCT00003301 Irinotecan in Treating Patients With Recurrent Malignant Glioma Status COMPLETED Phase PHASE1/PHASE2
NCT00003293 SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme Status COMPLETED Phase PHASE3
NCT00003273 Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor Status WITHDRAWN Phase PHASE2
NCT00003241 Phenylacetate in Treating Children With Recurrent or Progressive Brain Tumors Status COMPLETED Phase PHASE2
NCT00003234 Vinorelbine in Treating Children With Recurrent or Refractory Cancers Status COMPLETED Phase PHASE2
NCT00003211 Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor Status COMPLETED Phase PHASE2
NCT00003185 Biological Therapy in Treating Patients With Glioblastoma Multiforme Status COMPLETED Phase PHASE2